Microsoft buys genetic data software from Merck
Wall Street Journal, June 3, 2009
Microsoft continued its push into healthcare through a deal with Merck to gain access to some genetic data-management software. Microsoft plans to incorporate the genetic and genomic data-management software into Microsoft Amalga Life Sciences. Amalga is part of a push by Microsoft, whose other offerings include patient health-records holder HealthVault, to become a bigger player in healthcare.
Most Viewed
Most Emailed
- Urologists 'Outraged' Over PSA Test Challenge
- New Facebook Page Gathers Stories of Medical Harm
- Luxury Hospital Facilities Put Patient Experience First
- Five Hospitals Share Three Secrets to Improve Knee Surgery Outcomes
- Heartland Health Joins Mayo Clinic Network
- Beleaguered Fairview Health CEO to Retire in July
- Health Insurance Exchanges Put Defined Benefits to the Test
- Challenging Physicians to Help Improve the ED
- For hospitals and insurers, new fervor to cut costs
- The Power of Plugged-In Physicians

